| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Anatomical and Cellular Pathology [D. P. H., K-W. L., S-T. C., J. C. K. L.], Surgery, Divisionof Otorhinolaryngology [C. A. v. H., J. K. S. W.], and Clinical Oncology [P. H. K. C., S-F. L.], Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, and Department of Otolaryngology, Division of Head and Neck Cancer Research, Johns Hopkins University, Baltimore, Maryland 21205-2196 [P. C., D. S.]
Using 21 microsatellite polymorphic markers spanning both p and q arms, we have performed detailed deletion mapping on chromosome 9 in 18 primary nasopharyngeal carcinomas. All 18 tumors were informative at multiple loci. Eleven of the 18 cases (61%) demonstrated allelic deletion of chromosome 9. Among these 11, 6 cases are likely to be tumors with monosomy of chromosome 9. The other 5 cases demonstrated partial deletion by showing multiple areas of allelic loss. In one of the 5 cases, a homozygous deletion region was identified which includes D9S126, D9S171, and IFNA loci at 9p2122, situated between loci D9S161 (9p21) and D9S162 (9p2122). The presence of a homozygous deletion strongly suggests the presence of tumor suppressor gene(s) involved in the tumorigenesis of nasopharyngeal carcinoma. The same region has been reported to include some potential tumor suppressor gene loci in other cancers. This is the first reported finding of frequent genetic loss observed on chromosome 9 in nasopharyngeal carcinomas in addition to allelic loss on chromosome 3p at specific regions. Our results suggest that tumorigenesis and progression of nasopharyngeal carcinomas, like other solid tumors, involves multiple genetic changes associated with the inactivation of tumor suppressor genes.
1 Supported by University and Polytechnic Grants Committee, Hong Kong Grant CUHK52/93M and by the Croucher Foundation.
2 To whom requests for reprints should be addressed.
Received 4/28/94. Accepted 6/ 9/94.
This article has been cited by other articles:
![]() |
A.-L. Cheng, W.-G. Huang, Z.-C. Chen, F. Peng, P.-F. Zhang, M.-Y. Li, F. Li, J.-L. Li, C. Li, H. Yi, et al. Identification of Novel Nasopharyngeal Carcinoma Biomarkers by Laser Capture Microdissection and Proteomic Analysis Clin. Cancer Res., January 15, 2008; 14(2): 435 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B.-Y. Hui, Y. Y.-Y. Or, H. Takano, R. K.-Y. Tsang, K.-F. To, X.-Y. Guan, J. S.-T. Sham, K. W.-K. Hung, C. N.-Y. Lam, C. A. van Hasselt, et al. Array-Based Comparative Genomic Hybridization Analysis Identified Cyclin D1 as a Target Oncogene at 11q13.3 in Nasopharyngeal Carcinoma Cancer Res., September 15, 2005; 65(18): 8125 - 8133. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ma, J. Zhou, S. Fan, L. Wang, X. Li, Q. Yan, M. Zhou, H. Liu, Q. Zhang, H. Zhou, et al. Role of a novel EGF-like domain-containing gene NGX6 in cell adhesion modulation in nasopharyngeal carcinoma cells Carcinogenesis, February 1, 2005; 26(2): 281 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xiong, Z. Y. Zeng, J. H. Xia, K. Xia, S. R. Shen, X. L. Li, D. X. Hu, C. Tan, J. J. Xiang, J. Zhou, et al. A Susceptibility Locus at Chromosome 3p21 Linked to Familial Nasopharyngeal Carcinoma Cancer Res., March 15, 2004; 64(6): 1972 - 1974. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. C. Chan, P. M. L. Teo, and P. J. Johnson Nasopharyngeal carcinoma Ann. Onc., July 1, 2002; 13(7): 1007 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. C. Chan, K. F. To, K. W. Lo, K. F. Mak, W. Pak, B. Chiu, G. M. K. Tse, M. Ding, X. Li, J. C. K. Lee, et al. High Frequency of Chromosome 3p Deletion in Histologically Normal Nasopharyngeal Epithelia from Southern Chinese Cancer Res., October 1, 2000; 60(19): 5365 - 5370. [Abstract] [Full Text] |
||||
![]() |
K.-W. Lo, P. M. L. Teo, A. B.-Y. Hui, K.-F. To, Y.-S. Tsang, S. Y.-Y. Chan, K.-F. Mak, J. C. K. Lee, and D. P. Huang High Resolution Allelotype of Microdissected Primary Nasopharyngeal Carcinoma Cancer Res., July 1, 2000; 60(13): 3348 - 3353. [Abstract] [Full Text] |
||||
![]() |
J.-Y. Ko, L. T. Lui, T.-S. Sheen, P.-J. Lou, and M.-M. Hsu Increased Mutagen Sensitivity in Patients With Head and Neck Cancer Is Less Pronounced in Patients With Nasopharyngeal Carcinoma Arch Otolaryngol Head Neck Surg, May 1, 1998; 124(5): 578 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cheng, N. E. Poulos, M. L. Lung, G. Hampton, B. Ou, M. I. Lerman, and E. J. Stanbridge Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3 PNAS, March 17, 1998; 95(6): 3042 - 3047. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |